Humana (NYSE:HUM) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
Total Ratings | 3 | 3 | 9 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 2 | 0 | 0 |
2M Ago | 1 | 2 | 2 | 0 | 0 |
3M Ago | 2 | 1 | 4 | 0 | 0 |
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $364.33, accompanied by a high estimate of $396.00 and a low estimate of $310.00. Experiencing a 8.61% decline, the current average is now lower than the previous average price target of $398.67.
Understanding Analyst Ratings: A Comprehensive Breakdown
An in-depth analysis of recent analyst actions unveils how financial...